Ouabain is a specific inhibitor of sodium, potassium-dependent adenosine tr
iphosphatase (Na,K-ATPase), a P-type ion-transporting ATPase which is essen
tial for the maintenance of adequate concentrations of intracellular Na+ an
d K+ ions. The present study describes the establishment of a ouabain-resis
tant mutant, TLouaR, from a human trophoblast cell line TL. Morphologically
TL and TLouaR are indistinguishable, but, TLouaR is about 1000 times more
resistant to the cytotoxic effect of ouabain and >2000 times to that of buf
alin and yet ouabain can retard the growth of the TLouaR cells and in paral
lel reduce its cloning efficiency in a time- and dose-dependent manner. Fur
thermore, Na,K-ATPase activity from TLouaR cells is inhibitable by ouabain
albeit with lower efficiency, [H-3]ouabain binding studies reveal that TLou
aR cells have less (P < 0.05) ouabain binding sites (1.7 +/- 0.15 x 10(4)/c
ell vs, 2.3+/-0.115 x 10(4)/cell in the control). However, affinities (diss
ociation constants K-d) to ouabain for TL and TLouaR cells are not signific
antly different. Lastly, Na,K-ATPase activity (1.375 +/- 0.25 <mu>mole ATP/
min . mg protein) of TLouaR cells is significantly higher (P < 0.05) than t
hat of the TL cells (0.895 +/- 0.12 <mu>mole ATP/min . mg protein). These s
tudies show that the interactions between ouabain and Na,K-ATPase can be me
diated through different pathways resulting in diverse phenotypic character
istics. In addition, ouabain resistance does not necessarily reflect the la
ck of response to the digitalis drug. The exact mechanisms of ouabain resis
tance observed in the present study remain to be determined but the TLouaR
cells may be the best tool to uncover the many functional characteristics o
f Na,K-ATPase.